Levonorgestrel And Ethinyl Estradiol
Product Images NDC 0378-6550

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Levonorgestrel And Ethinyl Estradiol (NDC 0378-6550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Chemical structure diagram of the active ingredient Levonorgestrel, showing its steroidal molecular framework with labeled functional groups and bonds.*

FDA Label Image

Image 02

Chemical structure of Levonorgestrel and Ethinyl Estradiol, showing the detailed arrangement of carbon rings, hydroxyl groups, and alkyne functional group characteristic of this combined hormonal ingredient.*

FDA Label Image

Image 03

A horizontal bar chart comparing the number of women with blood clots per 10,000 women years among different groups: Non-Pregnant Non-COC users (1 to 5 cases), COC users (3 to 9 cases), Pregnant women (5 to 20 cases), and Postpartum women (12 weeks only) with 40 to 65 cases. Pregnancy data is based on a model assuming nine months duration.*

FDA Label Image

Image 04

A vertical arrow chart illustrating contraceptive methods from fewer to more pregnancies per 100 women in one year. Methods associated with fewer pregnancies include implants, injections, intrauterine devices, and sterilization. Birth control pills, skin patch, and vaginal ring are next, followed by condoms and diaphragms. No sex during fertile days, spermicide, and withdrawal correspond to higher pregnancy rates, with no birth control showing the highest pregnancy rate.*

FDA Label Image

Image 05

A diagram labeled Figure A showing a 28-day pill tablet layout for Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/30 mcg. It includes four weekly rows of circular tablet placeholders, each labeled with days of the week from Sunday to Saturday, with directional arrows indicating the sequence for daily pill intake. The NDC code 0378-6550-85 and Rx only designation are displayed on the panel.*

FDA Label Image

Image 06

Packaging label for Levonorgestrel and Ethinyl Estradiol Tablets, USP, containing 0.15 mg levonorgestrel and 30 mcg ethinyl estradiol. The label indicates it's an oral contraceptive by Mylan Pharmaceuticals Inc. It shows the package contains 3 pouches with 28 tablets each, and includes storage instructions and dosing summary.*

FDA Label Image

Image 08

A forest plot comparing effect estimates from multiple studies examining combined oral contraceptive (COC) use versus non-use. The horizontal axis shows effect estimates ranging from -1.50 to 2.00. Each study is listed with markers and confidence intervals representing odds ratios (OR), relative risks (RR), or hazard ratios (HR). The plot includes data from studies such as NICHD Women's Care Study, French E3N cohort, and others, showing effect sizes centered around 1.00 with varying confidence intervals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.